Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001625101-22-000024
Filing Date
2022-04-01
Accepted
2022-04-01 16:41:42
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A plse-20220401xdefa14a.htm DEFA14A 11080
2 GRAPHIC plse-20220401xdefa14ag001.jpg GRAPHIC 67533
3 GRAPHIC plse-20220401xdefa14ag002.jpg GRAPHIC 56503
  Complete submission text file 0001625101-22-000024.txt   183259
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37744 | Film No.: 22798928
SIC: 3841 Surgical & Medical Instruments & Apparatus